SDOS查詢結果

語文

總筆數:105

篇名作者刊名出版年查看
Risk factors for the development of recurrent atrial fibrillation: Role ofpacing and clinical variables Reimold, S.C.;Lamas, G.A.;Cantillon, C.O.;Antman, E.M.; American Heart Journal 1995-06-01 查看
Reply Reimold, S.C.;Antman, E.M.; American Heart Journal 1996-06-01 查看
Magnesium in acute myocardial infarction: Overview of available evidence Antman, E.M.; American Heart Journal 1996-08-01 查看
Current incidence and determinants of perioperative myocardial infarctionin coronary artery surgery Greaves, S.C.;Rutherford, J.D.;Aranki, S.F.;Cohn, L.H.;Couper, G.S.;Adams, D.H.;Rizzo, R.J.;Collins, J.J.;Antman, E.M.; American Heart Journal 1996-09-01 查看
Detection of unsuspected myocardial necrosis by rapid bedside assay forcardiac troponin T From the ^aCardiovascular Division, Department of Medicine; ^bClinical;Chemistry Laboratory, Department of Pathology; and ^cDepartment of;Pathology, Cardiac Pathology Division, Brigham and Women's Hospital,;Harvard Medical School.;Antman, E.M.;Grudzien, C.;Mitchell, R.N.;Sacks, D.B.; American Heart Journal 1997-05-01 查看
Myoglobin, creatine kinase MB, and cardiac troponin-I to assessreperfusion after thrombolysis for acute myocardial infarction: Resultsfrom TIMI 10A Tanasijevic, M.J.;Cannon, C.P.;Wybenga, D.R.;Fischer, G.A.;Grudzien, C.;Gibson, C.;Winkelman, J.W.;Antman, E.M.;Braunwald, E.; American Heart Journal 1997-10-01 查看
Myoglobin, creatine kinase MB, and cardiac troponin-I to assessreperfusion after thrombolysis for acute myocardial infarction: Resultsfrom TIMI 10A Tanasijevic, M.J.;Cannon, C.P.;Wybenga, D.R.;Fischer, G.A.;Grudzien, C.;Gibson, C.;Winkelman, J.W.;Antman, E.M.;Braunwald, E.; American Heart Journal 1997-10-01 查看
TIMI 11B. Enoxaparin versus unfractionated heparin for unstable anginaor non-Q-wave myocardial infarction: A double-blind, placebo-controlled,parallel-group, multicenter trial. Rationale, study design, and methods the Thrombolysis in Myocardial Infarction (TIMI) 11B Trial Investigators;Antman, E.M.; American Heart Journal 1998-06-01 查看
Trends in the use of pharmacotherapies for acute myocardial infarctionamong physicians who design and/or implement randomized trials versusphysicians in routine clinical practice: the MILIS-TIMI experience For the TIMI Investigators;Kizer, J.R.;Cannon, C.P.;McCabe, C.H.;Mueller, H.S.;Schweiger, M.J.;Davis, V.G.;Perritt, R.;Antman, E.M.; American Heart Journal 1999-01-01 查看
Trends in the use of pharmacotherapies for acute myocardial infarctionamong physicians who design and/or implement randomized trials versusphysicians in routine clinical practice: the MILIS-TIMI experience For the TIMI Investigators;Kizer, J.R.;Cannon, C.P.;McCabe, C.H.;Mueller, H.S.;Schweiger, M.J.;Davis, V.G.;Perritt, R.;Antman, E.M.; American Heart Journal 1999-01-01 查看
Trends in the use of pharmacotherapies for acute myocardial infarctionamong physicians who design and/or implement randomized trials versusphysicians in routine clinical practice: the MILIS-TIMI experience For the TIMI Investigators;Kizer, J.R.;Cannon, C.P.;McCabe, C.H.;Mueller, H.S.;Schweiger, M.J.;Davis, V.G.;Perritt, R.;Antman, E.M.; American Heart Journal 1999-01-01 查看
Diagnostic performance of cardiac troponin I in suspected acute myocardialinfarction: Implications for clinicians Tanasijevic, M.J.;Antman, E.M.; American Heart Journal 1999-02-01 查看
Diagnostic performance of cardiac troponin I in suspected acutemyocardial infarction: Implications for clinicians Tanasijevic, M.J.;Antman, E.M.; American Heart Journal 1999-02-01 查看
Methodologic drift in the assessment of TIMI grade 3 flow and itsimplications with respect to the reporting of angiographic trial results For the TIMI Study Group;Gibson, C.;Ryan, K.A.;Kelley, M.;Rizzo, M.J.;Mesley, R.;Murphy, S.;Swanson, J.;Marble, S.J.;Dodge, J.;Giugliano, R.P.;Cannon, C.P.;Antman, E.M.; American Heart Journal 1999-06-01 查看
Methodologic drift in the assessment of TIMI grade 3 flow and itsimplications with respect to the reporting of angiographic trial results For the TIMI Study Group;Gibson, C.;Ryan, K.A.;Kelley, M.;Rizzo, M.J.;Mesley, R.;Murphy, S.;Swanson, J.;Marble, S.J.;Dodge, J.;Giugliano, R.P.;Cannon, C.P.;Antman, E.M.; American Heart Journal 1999-06-01 查看
Newer antithrombin agents in acute coronary syndromes Antman, E.M.;Cohen, M.; American Heart Journal 1999-12-01 查看
Newer antithrombin agents in acute coronary syndromes Antman, E.M.;Cohen, M.; American Heart Journal 1999-12-01 查看
Guidelines for the diagnosis and management of unstable angina andnon-Q-wave myocardial infarction: Proposed revisions Antman, E.M.;Fox, K.M.;The International Cardiology Forum; American Heart Journal 2000-03-01 查看
Very early risk stratification after thrombolytic therapy with a bedsidemyoglobin assay and the 12-lead electrocardiogram de Lemos, J.A.;Antman, E.M.;Giugliano, R.P.;Morrow, D.A.;McCabe, C.H.;Charlesworth, A.;Schroder, R.;Braunwald, E.;for the InTIME-II investigators; American Heart Journal 2000-09-01 查看
Very early risk stratification after thrombolytic therapy with a bedsidemyoglobin assay and the 12-lead electrocardiogram de Lemos, J.A.;Antman, E.M.;Giugliano, R.P.;Morrow, D.A.;McCabe, C.H.;Charlesworth, A.;Schroder, R.;Braunwald, E.;for the InTIME-II investigators; American Heart Journal 2000-09-01 查看
Very early risk stratification after thrombolytic therapy with abedside myoglobin assay and the 12-lead electrocardiogram for the InTIME-II investigators;de Lemos, J.A.;Antman, E.M.;Giugliano, R.P.;Morrow, D.A.;McCabe, C.H.;Charlesworth, A.;Schroder, R.;Braunwald, E.; American Heart Journal 2000-09-01 查看
Superiority of enoxaparin versus unfractionated heparin for unstableangina/non-Q-wave myocardial infarction regardless of activated partialthromboplastin time Bozovich, G.E.;Gurfinkel, E.P.;Antman, E.M.;McCabe, C.H.;Mautner, B.;for the TIMI 11B investigators; American Heart Journal 2000-10-01 查看
Superiority of enoxaparin versus unfractionated heparin for unstableangina/non-Q-wave myocardial infarction regardless of activated partialthromboplastin time Bozovich, G.E.;Gurfinkel, E.P.;Antman, E.M.;McCabe, C.H.;Mautner, B.;for the TIMI 11B investigators; American Heart Journal 2000-10-01 查看
Superiority of enoxaparin versus unfractionated heparin for unstableangina/non-Q-wave myocardial infarction regardless of activated partialthromboplastin time Bozovich, G.E.;Gurfinkel, E.P.;Antman, E.M.;McCabe, C.H.;Mautner, B.;for the TIMI 11B investigators; American Heart Journal 2000-10-01 查看
Prior aspirin users with acute non-ST-elevation coronary syndromes are atincreased risk of cardiac events and benefit from enoxaparin Santopinto, J.;Gurfinkel, E.P.;Torres, V.;Marcos, E.;Bozovich, G.E.;Mautner, B.;McCabe, C.H.;Antman, E.M.; American Heart Journal 2001-04-01 查看
Abciximab and early adjunctive percutaneous coronary intervention areassociated with improved ST-segment resolution after thrombolysis:Observations from the TIMI 14 Trial de Lemos, J.A.;Gibson, C.M.;Antman, E.M.;Murphy, S.A.;Morrow, D.A.;Schuhwerk, K.C.;Schweiger, M.;Coussement, P.;Van de Werf, F.;Braunwald, E.;for the TIMI 14 Investigators; American Heart Journal 2001-04-01 查看
Prior aspirin users with acute non-ST-elevation coronary syndromes are atincreased risk of cardiac events and benefit from enoxaparin Santopinto, J.;Gurfinkel, E.P.;Torres, V.;Marcos, E.;Bozovich, G.E.;Mautner, B.;McCabe, C.H.;Antman, E.M.; American Heart Journal 2001-04-01 查看
Abciximab and early adjunctive percutaneous coronary intervention areassociated with improved ST-segment resolution after thrombolysis:Observations from the TIMI 14 Trial de Lemos, J.A.;Gibson, C.M.;Antman, E.M.;Murphy, S.A.;Morrow, D.A.;Schuhwerk, K.C.;Schweiger, M.;Coussement, P.;Van de Werf, F.;Braunwald, E.;for the TIMI 14 Investigators; American Heart Journal 2001-04-01 查看
Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.;, for the Thrombolysis in Myocardial Infarction (TIMI) Investigators; American Heart Journal 2001-05-01 查看
Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.;, for the Thrombolysis in Myocardial Infarction (TIMI) Investigators; American Heart Journal 2001-05-01 查看
Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.;for the Thrombolysis in Myocardial Infarction (TIMI) Investigators; American Heart Journal 2001-05-01 查看
Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage for the Thrombolysis in Myocardial Infarction (TIMI) Investigators;Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.; American Heart Journal 2001-05-01 查看
Myoglobin levels at 12 hours identify patients at low risk for 30-daymortality after thrombolysis in acute myocardial infarction: A Thrombolysisin Myocardial Infarction 10B substudy Srinivas, V.S.;Cannon, C.P.;Gibson, C.M.;Antman, E.M.;Greenberg, M.A.;Tanasijevic, M.J.;Murphy, S.;de Lemos, J.A.;Sokol, S.;Braunwald, E.;Mueller, H.S.; American Heart Journal 2001-07-01 查看
Myoglobin levels at 12 hours identify patients at low risk for 30-daymortality after thrombolysis in acute myocardial infarction: A Thrombolysisin Myocardial Infarction 10B substudy Srinivas, V.S.;Cannon, C.P.;Gibson, C.;Antman, E.M.;Greenberg, M.A.;Tanasijevic, M.J.;Murphy, S.;de Lemos, J.A.;Sokol, S.;Braunwald, E.;Mueller, H.S.; American Heart Journal 2001-07-01 查看
Are activated clotting times helpful in the management of anticoagulationwith subcutaneous low-molecular-weight heparin? Henry, T.D.;Satran, D.;Knox, L.L.;Iacarella, C.L.;Laxson, D.D.;Antman, E.M.; American Heart Journal 2001-10-01 查看
Are activated clotting times helpful in the management of anticoagulationwith subcutaneous low-molecular-weight heparin? Henry, T.D.;Satran, D.;Knox, L.L.;Iacarella, C.L.;Laxson, D.D.;Antman, E.M.; American Heart Journal 2001-10-01 查看
Are activated clotting times helpful in the management ofanticoagulation with subcutaneous low-molecular-weight heparin? Henry, T.D.;Satran, D.;Knox, L.L.;Iacarella, C.L.;Laxson, D.D.;Antman, E.M.; American Heart Journal 2001-10-01 查看
Are activated clotting times helpful in the management ofanticoagulation with subcutaneous low-molecular-weight heparin? Henry, T.D.;Satran, D.;Knox, L.L.;Iacarella, C.L.;Laxson, D.D.;Antman, E.M.; American Heart Journal 2001-10-01 查看
A second look at bivalirudin Antman, E.M.;Braunwald, E.; American Heart Journal 2001-12-01 查看
A second look at bivalirudin Antman, E.M.;Braunwald, E.; American Heart Journal 2001-12-01 查看
A second look at bivalirudin Antman, E.M.;Braunwald, E.; American Heart Journal 2001-12-01 查看
Mode and timing of treatment failure (recurrent ischemic events) afterhospital admission for non-ST segment elevation acute coronary syndromes Cohen, M.;Antman, E.M.;Murphy, S.A.;Radley, D.; American Heart Journal 2002-01-01 查看
Mode and timing of treatment failure (recurrent ischemic events) afterhospital admission for non-ST segment elevation acute coronary syndromes Cohen, M.;Antman, E.M.;Murphy, S.A.;Radley, D.; American Heart Journal 2002-01-01 查看
Bivalirudin as a replacement for unfractionated heparin in unstableangina/non-ST-elevation myocardial infarction: Observations from the TIMI 8trial Antman, E.M.;McCabe, C.H.;Braunwald, E.;for the TIMI 8 Investigators; American Heart Journal 2002-02-01 查看
Bivalirudin as a replacement for unfractionated heparin in unstableangina/non-ST-elevation myocardial infarction: Observations from the TIMI 8trial Antman, E.M.;McCabe, C.H.;Braunwald, E.;for the TIMI 8 Investigators; American Heart Journal 2002-02-01 查看
Influence of patient characteristics and renal function on factor Xainhibition pharmacokinetics and pharmacodynamics after enoxaparinadministration in non-ST-segment elevation acute coronary syndromes Becker, R.C.;Spencer, F.A.;Gibson, M.;Rush, J.E.;Sanderink, G.;Murphy, S.A.;Ball, S.P.;Antman, E.M.;for the TIMI 11A Investigators; American Heart Journal 2002-05-01 查看
Influence of patient characteristics and renal function on factor Xainhibition pharmacokinetics and pharmacodynamics after enoxaparinadministration in non-ST-segment elevation acute coronary syndromes Becker, R.C.;Spencer, F.A.;Gibson, M.;Rush, J.E.;Sanderink, G.;Murphy, S.A.;Ball, S.P.;Antman, E.M.;for the TIMI 11A Investigators; American Heart Journal 2002-05-01 查看
Influence of patient characteristics and renal function on factor Xainhibition pharmacokinetics and pharmacodynamics after enoxaparinadministration in non-ST-segment elevation acute coronary syndromes for the TIMI 11A Investigators;Becker, R.C.;Spencer, F.A.;Gibson, M.;Rush, J.E.;Sanderink, G.;Murphy, S.A.;Ball, S.P.;Antman, E.M.; American Heart Journal 2002-05-01 查看
Influence of patient characteristics and renal function on factor Xainhibition pharmacokinetics and pharmacodynamics after enoxaparinadministration in non-ST-segment elevation acute coronary syndromes Becker, R.C.;Spencer, F.A.;Gibson, M.;Rush, J.E.;Sanderink, G.;Murphy, S.A.;Ball, S.P.;Antman, E.M.;for the TIMI 11A Investigators; American Heart Journal 2002-05-01 查看
Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; American Heart Journal 2002-06-01 查看
Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; American Heart Journal 2002-06-01 查看
Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; American Heart Journal 2002-06-01 查看
上一頁 第1頁/共3頁/跳至 下一頁